German Chancellor Olaf Scholz and Merck Celebrate Laying for Advanced Research Facility Darmstadt, Germany — This Thursday, Merck announced an investment of over €300 million in the construction of a new research center at its headquarters in Darmstadt, Germany. The new facility, named the Advanced Research Center, will focus on developing bio-pharmaceutical products including antibodies, … Continue reading Update: Merck Invests €300 Million in New Bio-Pharmaceutical Research Center